Skip to main content
. 2025 Jun 27;12(36):e05538. doi: 10.1002/advs.202505538

Figure 5.

Figure 5

Drug release characterization and therapeutic activity of minicellDOX biohybrids. a) pH‐responsive cumulative release of DOX encapsulated in minicells for a two‐week period at pH 4.6, 6.5 and 7.4. b) Fluorescence microscopy images of in vitro drug uptake of SK‐BR‐3 cells incubated with minicellDOX for 0, 24 and 48 h. DOX inside the cells was shown by the red color. Scale bar: 20 µm. c) Quantification of mean DOX fluorescence intensity on SK‐BR‐3 cells over time. The mean ± SD for n ≥10, *** P = 0.0010, **** P < 0.0001, t‐test. d) The percent viability of SK‐BR‐3 cells incubated with free DOX, minicell biohybrids and minicellDOX biohybrids with and without magnetic actuation at pH 6.5 for 24 h. The error bars represent the SD of the mean for n = 3; ns: not significant, ** P < 0.0018, **** P < 0.0001 ANOVA. In all experiments shown in this figure, drug loading into minicells was performed by overnight incubation of minicells with DOX at a concentration of 40 µg mL−1.